Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
3.52
Nov 20 • 12:48 PM ET Dollar change-2.65 Percentage change(-42.95%)
Today, 10:02 AMNo clear catalyst identified for Zoar 34% gap-down after NYSE American listing
Index
-
Market Cap
31.50M
Enterprise Value
34.73M
Income
1.61M
Sales
0.04M
Book/sh
1.18
Cash/sh
0.00
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
8
IPO
Sep 16, 2024
P/E
16.96
Forward P/E
-
PEG
-
P/S
787.44
P/B
2.97
P/C
1574.87
P/FCF
262.48
EV/EBITDA
-
EV/Sales
868.19
Quick Ratio
0.02
Current Ratio
0.04
Debt/Eq
0.00
LT Debt/Eq
0.00
Option/Short
No / Yes
EPS (ttm)
0.21
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
15.09% -48.52%
Sales past 3/5Y
- -
EPS Y/Y TTM
100.44%
Sales Y/Y TTM
52.00%
EPS Q/Q
95.04%
Sales Q/Q
16.67%
Earnings
-
EPS/Sales Surpr.
- -
Insider Own
7.36%
Insider Trans
-0.14%
Inst Own
3.58%
Inst Trans
0.29%
ROA
9.32%
ROE
371.29%
ROIC
15.95%
Gross Margin
-4026.32%
Oper. Margin
-12623.68%
Profit Margin
4247.37%
SMA20
-16.91%
SMA50
-26.36%
SMA200
-42.87%
Trades
Shs Outstand
8.54M
Shs Float
7.91M
52W High
10.47 -66.39%
52W Low
2.43 44.86%
Volatility
10.21% 15.39%
ATR (14)
0.77
RSI (14)
42.93
Beta
1.38
Rel Volume
1.77
Avg Volume
17.62K
Volume
16,708
Perf Week
-31.52%
Perf Month
-7.37%
Perf Quarter
-38.43%
Perf Half Y
-48.71%
Perf YTD
-44.77%
Perf Year
-38.02%
Perf 3Y
-
Perf 5Y
-
Perf 10Y
-
Recom
-
Target Price
-
Prev Close
6.17
Price
3.52
Change %
-42.95%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DSS, INC.10% OwnerSep 24 '26Sale7.061561,101589,518Sep 24 07:37 PM
DSS, INC.10% OwnerSep 22 '26Sale0.55723398589,701Sep 24 07:37 PM
DSS, INC.10% OwnerSep 23 '26Sale6.9527188589,674Sep 24 07:37 PM
DSS INC.StockholderApr 22 '26Proposed Sale0.7231,939,77823,064,209Apr 29 06:08 PM
Macko Todd DChief Financial OfficerMar 27 '26Sale0.5643,40024,369155,122Mar 30 09:06 PM
Macko Todd DChief Financial OfficerMar 25 '26Sale0.601,600961198,122Mar 30 09:06 PM
Grady JasonDirectorMar 23 '26Sale0.6550,00032,505250,182Mar 25 07:55 PM
Develops, manufactures and markets API orphan drugs
J.D.Mr. Frank D. Heuszel Esq.
CFOMr. Todd D. Macko C.P.A.
Chief Operating OfficerMr. Mark J. Suseck